Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONStandard

CORTROSYN

COSYNTROPIN

Standard Dose
0.25MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview CORTROSYN is listed in Drugs@FDA under application 016750 (NDA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient COSYNTROPIN Form and strength INJECTABLE;INJECTION - 0.25MG/VIAL Sponsor AMPHASTAR PHARMS INC Submission history Latest submission status date: 2023-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview CORTROSYN is listed in Drugs@FDA under application 016750 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient COSYNTROPIN Form and strength INJECTABLE;INJECTION - 0.25MG/VIAL Sponsor AMPHASTAR PHARMS INC Submission history Latest submission status date: 2023-12-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.